Cargando…
Sustained specialized and family treatment in first-episode schizophrenia or related disorders: a 5-year randomized controlled trial
BACKGROUND: The long-term outcome of first-episode schizophrenia needs improvement. Here, we evaluate the effectiveness of 5 years sustained specialist treatment (ST), ST including Parent groups (ST + P) or treatment as usual (TAU) on psychotic relapse and social functioning. METHODS: A three condit...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388306/ https://www.ncbi.nlm.nih.gov/pubmed/35672956 http://dx.doi.org/10.1017/S003329172200099X |
_version_ | 1785082085251219456 |
---|---|
author | de Haan, Lieuwe Linszen, Don Wouters, Luuk Zwinderman, Koos Dingemans, Peter |
author_facet | de Haan, Lieuwe Linszen, Don Wouters, Luuk Zwinderman, Koos Dingemans, Peter |
author_sort | de Haan, Lieuwe |
collection | PubMed |
description | BACKGROUND: The long-term outcome of first-episode schizophrenia needs improvement. Here, we evaluate the effectiveness of 5 years sustained specialist treatment (ST), ST including Parent groups (ST + P) or treatment as usual (TAU) on psychotic relapse and social functioning. METHODS: A three condition randomized, parallel assigned, single-blind efficacy trial, in which 198 first-episode psychosis (FEP) patients aged 15–28 years were included. The effect on time to first relapse, first relapse rates, mean number of relapses per patient, and time to the improvement of social functioning were analyzed using Cox regression or ANOVA. RESULTS: We found no significant differences between treatment conditions in the ITT analysis concerning time to first relapse, nor first relapse rate. Mean number of relapses per patient differed at a trend level between ST, ST + P or TAU conditions, respectively: 0.72; 0.62 or 1.02 (p = 0.069). No evidence was found for differential effect of treatment conditions on social functioning. CONCLUSION: Five years sustained ST of FEP nor addition of parent groups increased time to first relapse or reduced first relapse rate, compared to sustained TAU. Indications for favorable effects of parent groups were found on relapses per patient. |
format | Online Article Text |
id | pubmed-10388306 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-103883062023-08-01 Sustained specialized and family treatment in first-episode schizophrenia or related disorders: a 5-year randomized controlled trial de Haan, Lieuwe Linszen, Don Wouters, Luuk Zwinderman, Koos Dingemans, Peter Psychol Med Original Article BACKGROUND: The long-term outcome of first-episode schizophrenia needs improvement. Here, we evaluate the effectiveness of 5 years sustained specialist treatment (ST), ST including Parent groups (ST + P) or treatment as usual (TAU) on psychotic relapse and social functioning. METHODS: A three condition randomized, parallel assigned, single-blind efficacy trial, in which 198 first-episode psychosis (FEP) patients aged 15–28 years were included. The effect on time to first relapse, first relapse rates, mean number of relapses per patient, and time to the improvement of social functioning were analyzed using Cox regression or ANOVA. RESULTS: We found no significant differences between treatment conditions in the ITT analysis concerning time to first relapse, nor first relapse rate. Mean number of relapses per patient differed at a trend level between ST, ST + P or TAU conditions, respectively: 0.72; 0.62 or 1.02 (p = 0.069). No evidence was found for differential effect of treatment conditions on social functioning. CONCLUSION: Five years sustained ST of FEP nor addition of parent groups increased time to first relapse or reduced first relapse rate, compared to sustained TAU. Indications for favorable effects of parent groups were found on relapses per patient. Cambridge University Press 2023-07 2022-06-08 /pmc/articles/PMC10388306/ /pubmed/35672956 http://dx.doi.org/10.1017/S003329172200099X Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. |
spellingShingle | Original Article de Haan, Lieuwe Linszen, Don Wouters, Luuk Zwinderman, Koos Dingemans, Peter Sustained specialized and family treatment in first-episode schizophrenia or related disorders: a 5-year randomized controlled trial |
title | Sustained specialized and family treatment in first-episode schizophrenia or related disorders: a 5-year randomized controlled trial |
title_full | Sustained specialized and family treatment in first-episode schizophrenia or related disorders: a 5-year randomized controlled trial |
title_fullStr | Sustained specialized and family treatment in first-episode schizophrenia or related disorders: a 5-year randomized controlled trial |
title_full_unstemmed | Sustained specialized and family treatment in first-episode schizophrenia or related disorders: a 5-year randomized controlled trial |
title_short | Sustained specialized and family treatment in first-episode schizophrenia or related disorders: a 5-year randomized controlled trial |
title_sort | sustained specialized and family treatment in first-episode schizophrenia or related disorders: a 5-year randomized controlled trial |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388306/ https://www.ncbi.nlm.nih.gov/pubmed/35672956 http://dx.doi.org/10.1017/S003329172200099X |
work_keys_str_mv | AT dehaanlieuwe sustainedspecializedandfamilytreatmentinfirstepisodeschizophreniaorrelateddisordersa5yearrandomizedcontrolledtrial AT linszendon sustainedspecializedandfamilytreatmentinfirstepisodeschizophreniaorrelateddisordersa5yearrandomizedcontrolledtrial AT woutersluuk sustainedspecializedandfamilytreatmentinfirstepisodeschizophreniaorrelateddisordersa5yearrandomizedcontrolledtrial AT zwindermankoos sustainedspecializedandfamilytreatmentinfirstepisodeschizophreniaorrelateddisordersa5yearrandomizedcontrolledtrial AT dingemanspeter sustainedspecializedandfamilytreatmentinfirstepisodeschizophreniaorrelateddisordersa5yearrandomizedcontrolledtrial |